Active, not recruiting
Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer
NCT05403385
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Highlands Oncology Group Fayetteville, Arkansas, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Algemeen Ziekenhuis Sint-Lucas Ghent, Belgium
- Jessa Ziekenhuis Hasselt, Belgium